Literature DB >> 408858

Movement disorders induced in monkeys by chronic haloperidol treatment.

B Weiss, S Santelli, G Lusink.   

Abstract

After several months of treatment, Cebus apella, Cebus albifrons, and Saimiri sciurea monkeys maintained on haloperidol, in doses of 0.5 or 1.0 mg/kg orally 5 days per week, began to display severe movement disorders, typically 1-6 h post-drug. Cebus monkeys exhibited violent, uncontrolled movements that flung the animals about the cage. Such episodes usually lasted only a few minutes, recurring several times during the period following drug ingestion. Writhing and bizarre postures dominated the response in S. sciurea. Cessation of drug treatment produced no distinctive after-effects. When tested as long as 508 days after the last administration, however, Cebus monkeys responded to haloperidol with several episodes of hyperkinesis, even at challenge doses considerably lower than those in the original treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408858     DOI: 10.1007/bf00492366

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Long-term effects of haloperidol.

Authors:  P L Man
Journal:  Dis Nerv Syst       Date:  1973-02

2.  Tardive and withdrawal dyskinesia associated with haloperidol.

Authors:  G Jacobson; R J Baldessarini; T Manschreck
Journal:  Am J Psychiatry       Date:  1974-08       Impact factor: 18.112

3.  Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatry.

Authors:  G E Crane
Journal:  Science       Date:  1973-07-13       Impact factor: 47.728

4.  Neurological syndromes associated with antipsychotic drug use. A special report.

Authors:  D X Freedman
Journal:  Arch Gen Psychiatry       Date:  1973-04

5.  Haloperidol for control of severe emotional reactions in mentally retarded patients.

Authors:  S W Grabowski
Journal:  Dis Nerv Syst       Date:  1973 Aug-Sep

6.  Haloperidol and electric shock interaction effects on tremors and on catecholamine concentrations in the caudate nucleus of the squirrel monkey.

Authors:  J M Ordy; T Samorajski; D M Schroeder; P Rady-Reimer
Journal:  Brain Res       Date:  1969-02       Impact factor: 3.252

7.  Alkylmercurial encephalopathy in the monkey (Saimiri sciureus and Macaca arctoides): a histopathologic and autoradiographic study.

Authors:  R H Garman; B Weiss; H L Evans
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

8.  Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.

Authors:  R D Eibergen; K R Carlson
Journal:  Pharmacol Biochem Behav       Date:  1976-08       Impact factor: 3.533

9.  Haloperidol-induced tardive dyskinesia in monkeys.

Authors:  L M Gunne; S Bárány
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

  9 in total
  15 in total

1.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.

Authors:  Geoffrey B Varty; Robert A Hodgson; Annamarie J Pond; Michael E Grzelak; Eric M Parker; John C Hunter
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

3.  Lack of tolerance to haloperidol-induced acute dyskinesias in rhesus monkeys.

Authors:  R D Porsolt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats.

Authors:  E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

5.  Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.

Authors:  R Neale; S Gerhardt; S Fallon; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Neuroleptic-induced acute dyskinesias in rhesus monkeys.

Authors:  R D Porsolt; M Jalfre
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys.

Authors:  R Neale; S Gerhardt; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Fluphenazine-induced acute and tardive dyskinesias in monkeys.

Authors:  B Kovacic; E F Domino
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Long-term chlorpromazine in rhesus monkeys: production of dyskinesias and changes in social behavior.

Authors:  W T McKinney; E C Moran; G W Kraemer; A J Prange
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.